Experimental Section: Synthesis.
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with saturated brine, dried with magnesium sulfate, filtered, and concentrated to give 172.0 mg of a crude oil. Purification by preparative TLC on 4 20!20 cm ! 1 mm thickness PK6F plates developed with 15 % ethanol in toluene afforded desired nonasaccharide 22b as a foam (122.8 mg, 29.8 µmol, 72 % yield) . R f = 0.35 (5 % ethanol in toluene).
["] D =+10.6° (c 3.5, CHCl 3 ); 1 H-NMR (500 MHz, CDCl 3 , selected signals), !: 0.07 (s, 3H), 0.10 (s, 3H), 0.94 (s, 9H), 1.71 (s, 3H), 1.74 (s, 3H), 5.05 (s, 1H), 5.11 (s, 1H), 5.23 (d, J=6.8 Hz, 1H), 5.59 (d, J=6.9 Hz, 1H), 7.69 (d, J=7.5 Hz, 2H), 7.77 (d, J=7.5 Hz, 2H) ; 13 C-NMR (125 MHz, CDCl 3 ), !: -5. 7, -4.5, 18.0, 26.4, 25.8, 29.7, 56.8, 57.4, 58.0, 58.2, 66.6, 67.6, 68.2, 68.5, 69.1, 69.2, 69.4, 69.9, 70.0, 70.9, 71.8, 72.6, 72.9, 73.2, 73.3, 73.4, 73.7, 73.9, 74.0, 74.3, 74.6, 74.9, 75.0, 75.1, 76.1, 76.2, 76.3, 76.9, 77.2, 77.6, 77.7, 77.8, 78.2, 78.6, 79.8, 79.8, 79.9, 81.2, 82.4, 92.7, 98.1, 98.2, 98.4, 99.6, 100.6, 101.9, 102.7, 102.9, 126.2, 126.9-128.8, 132.2, 132.3, 137.6, 138.0, 138.05, 138.1, 138.3, 138.4, 138.45, 138.5, 138.7, 138.8, 139.0, 139.1, 139.4, 139.5, 140.6, 141.2, 170.6, 170. To nonasaccharide 22b (122.8 mg, 29.8 µmmol) under argon in a 50 mL roundbottom flask fitted with a stirbar and a septum with an argon inlet was added acetic acid, 1.0 M in THF
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(2.0 mL, 2.0 mmol). Over an ice-water bath, TBAF, 1.0 M in THF (0.8 mL, 0.8 mmol, 27 equiv) was added, then the ice-bath was removed. After stirring for 21 hr at ambient temperature, the stirbar was rinsed and removed and the reaction mixture was concentrated at low pressure. The residue was transferred to a 60 mL separatory funnel with 30 mL ethyl acetate, washed with 2 ! 22.7, 22.9, 23.4, 23.7, 28.9, 29.3, 29.7, 30.3, 31.9, 38.7, 56.8, 57.0, 57.3, 58.4, 67.0, 67.8, 68.1, 68.2, 68.5, 68.8, 69.2, 69.5, 70.0, 70.8, 71.8, 72.6, 72.9, 73.2, 73.4, 73.7, 73.9, 74.0, 74.4, 74.6, 74.7, 75.0, 75.4, 76.0, 76.1, 77.2, 77.7, 78.1, 78.5, 79.5, 79.9, 81.3, 82.3, 82.4, 91.3, 98.2, 98.3, 99.6, 100.3, 101.8, 102.8, 102.9, 126.2, 127.0-128.8, 129.7, 130.8, 132.4, 132.5, 137.4, 138.0, 138.1, 138.2, 138.3, 138.4, 138.5, 138.7, 138.8, 138.9, 139.0, 139.4, 139.5, 140.2, 141.4, 170.6, 171 The starting material reducing saccharide 23 (20 mg, 12.2 µmol) in a 50 mL pear flask was dissolved in water (10 mL). To this clear, colorless solution was added solid ammonium hydrogencarbonate (6.28 g, 79.7 mmol); the suspension was stirred vigorously and heated S8 immediately to 40°C over a warm water bath. As the solution became almost clear, additional ammonium hydrogencarbonate was added at almost 2 hr., (2.99 g, 37.8 mmol) and at 8.5 hr.
(5.00 g, 63.2 mmol). At 30 hr., the cloudy reaction mixture was allowed to cool, with stirring.
The slurry was then transferred to a tared, 50 mL polypropylene conical tube, washed in with water to a total volume of 35 mL, immediately shell frozen, and lyophilized to give 650 mg white powder. This white powder was dissolved in 15 mL water, then immediately shell frozen and lyophilized again, affording 33.8 mg white powder. Similar lyophilization thrice more from 10 mL water (used to transfer the material to a 15 mL polypropylene conical tube) gave 28.0, 25.2, and 24.4 mg white or off-white solid. The ammonium bicarbonate seemed to be gone and the dry mass fairly constant when the lyophilized solid became relatively dense and granular. : 12.8, 17.4, 24.7, 24.9, 25.0, 25.1, 27.2, 27.4, 29.0, 30.9, 31.6, 33.0, 69.2, 39.3, 41.9, 43.3, 46.5, 47.3, 52.6, 55.4, 56.1, 56.4, 56.7, 57.6, 57.7, 58.2, 60.9, 62.7, 63.8, 64.4, 64.5, 68.5, 68.6, 70.0, 70.1, 71.3, 72.1, 72.9, 73.7, 74.7, 74.8, 75.2, 75.6, 76.3, 77.1, 77.4, 78.1, 79.0, 79.2, 81.0, 81.2, 81.4, 82.3, 83.1, 99.8, 102.1, 102 8, 68.8, 71.7, 73.5, 76.0, 79.3, 88.1, 101.9, 126.4, 128.0, 128.2, 128.3, 128.5, 128.8, 129.3, 129.4, 132.0, 133.6, 137.7, 138. To a solution of the 4,6-O-benzylidene protected compound 29 (120 mg, 0.266 mmol) stirred in ice bath under Ar was added dropwise 1M HCl in ethyl ether until gas evolution ceased completely, and then another 0.1 ml. The reaction mixture was stirred in ice bath for another 2h and then at room temperature for 0.5 h before quenching with sat. aq. sodium bicarbonate solution. The residue was extracted with chloroform and isolated by preparative TLC (ethyl acetate/ hexanes 1/2) to give the title product (92 mg, 77%) as a colorless oil. 68.5, 69.8, 70.4, 71.9, 72.4, 73.8, 79.9, 87.8, 127.8, 128.0, 128.1, 128.4, 128.6, 128.7, 129.0, 129.4, 131.9, 134.1, 137.9, 138 The diol 30a was benzoylated as described for 31 to give dibenzoyl protected material 30 in 98% (m, 4H). 13 C-NMR (CDCl 3 , 100 MHz), !: 68.9, 69.7, 70.5, 71.3, 71.6, 73.8, 74.9, 86.6, 127.7, 127.9, 128.0, 128.2, 128.3, 128.5, 128.6, 128.7, 128.8, 129.4, 129.8, 129.9, 130.2, 130.3, 132.5, 133.4, 133.5, 133.6, 137.5, 138.3, 165.8, 166. Benzylidine-protected mannoside 29 (98.6 mg, 219 µmol) was concentrated twice from dry toluene in a 25 mL roundbottom flask, which was then fitted with an oven-dried stirbar and a dry argon inlet. The flask was almost entirely submerged in an ice-water bath for 10 min, at which point a 1.0 M solution of borane-THF in THF (1.55 mL, 1.55 mmol, 7.08 equiv) was added slowly via syringe down the sides of the flask. After stirring 15 min, a 1.0 M solution of dibutylboron triflate in dichloromethane (0.22 mL, 220 µmol, 1.0 equiv) was added via syringe dropwise. The resulting solution was stirred for 90 min at 0° C, at which point triethylamine (0.12 mL, 861 µmol, 3.9 equiv) was added via syringe, then methanol (10 mL) was added, S15 dropwise at first. The mixture was concentrated, then concentrated three more times from 10 mL methanol to give an oily residue. Column chromatography on silica gel eluted with 40 %!50 % ethyl acetate in hexanes afforded diol 30a ( 7, 69.9, 72.2, 72.7, 74.0, 75.2, 80.0, 87.2, 127.7, 127.8, 128.0, 128.1, 128.4, 128.6, 129.1, 131.8, 133.3, 137.5, 138. Hz, 1H); 13 C-NMR (100 MHz, CDCl 3 ), !: 63. 5, 70.5, 70.9, 71.7, 73.9, 75.3, 78.6, 86.3, 127.8, 127.9, 128.2, 128.28, 128.33, 128.40, 128.42, 129.1, 129.66, 129.72, 129.8, 130.0, 131.9, 133.0, 133.3, 137.4, 137.7, 165.5, 166. A solution of thiomannoside donor 30 (180.0 mg, 0.27 mmol) in dry acetonitrile (1.75 ml) was stirred with 3A molecular sieves for 1 h and then cooled to 15 °C. The solution was then treated with solid promoter (BrC 6 H 4 ) 3 NSbCl 6 (210 mg, 0.34 mmol) followed by the trisaccharide acceptor 4 (129 mg, 0.09 mmol) in dry acetonitrile (0.75 ml). The reaction mixture was protected from light and stirred at 15 °C for 40 min before the addition of another portion of (BrC 6 H 4 ) 3 NSbCl 6 (48 mg, 0.08 mmol). Stirring was continued for another 12 h at room temperature at which point the reaction was quenched by addition of triethylamine, filtered through a Celite pad, and concentrated. The residue was purified by flash chromatography on silica gel (eluent: ethyl acetate/hexanes 1/2) and then by preparative TLC (eluent: ethyl acetate/toluene 1/5) to afford starting trisaccharide acceptor 4 (18 mg) and desired -4.4, 18.0, 25.8, 58.0, 58.7, 67.1, 67.6, 68.1, 68.2, 68.6, 69.5, 69.7, 70.7, 71.1, 73.4, 73.5, 73.6, 73.7, 74.0, 74.6, 75.2, 75.3, 76.0, 76.3, 77.2, 78.2, 78.3, 80.0, 92.8, 98.9, 100.9, 101.0, 101.1, 125.8, 127.0, 127.1, 127.3, 127.4, 127.5, 127.6, 127.65, 127.7, 127.8, 127.9, 128.0, 128.03, 128.1, 128.14, 128.2, 128.25, 128.3, 128.33, 128.4, 128.45, 128.5, 128.7, 128.8, 128.9, 129.3, 129.5, 129.7, 129.8, 129.9, 132.2, 132.3, 133.1, 133.2, 137.1, 137.4, 137.6, 137.8, 137.9, 138.4, 138.5, 140.7, 141.5, 165.39, 165.42 Stirring was continued at this temperature for 2 h and then the reaction was quenched by S18 sequential addition of triethylamine and methanol. The solution was concentrated and coevaporated with methanol 5 times. The residue was dried and subjected to preparative TLC -4.4, 18.0, 25.8, 57.9, 58.4, 61.3, 67.7, 68.4, 68.7, 68.8, 69.4, 69.9, 71.0, 71.1, 73.1, 73.4, 73.5, 73.6, 74.0, 74.1, 74.3, 74.6, 75.2, 76.0, 76.1, 76.9, 77.2, 77.5, 78.6, 79.7, 81.4, 92.8, 99.9, 100.8, 101.2, 126.6, 127.0, 127.06, 127.1, 127.2, 127.3, 127.34, 127.4, 127.44, 127.5, 127.6, 127.7, 127.75, 127.8, 127.87. 127.9, 128.0, 128.07, 128.1, 128.15, 128.2, 128.23, 128.26, 128.3, 128.4, 128.45, 128.5, 128.52, 128.62, 128.8, 129.0, 129.5, 129.6, 129.8, 130.0, 132.3, 132.4, 133.1, 133.2, 137.3, 137.7, 137.8, 137.9, 138.3, 138.4, 138.9, 140.7, 141.1, 165.3, 165. -4.42, 18.03, 25.82, 58.0, 58.5, 66.3, 67.6, 67.7, 67.8, 67.9, 68.8, 69.0, 69.8, 70.4, 71.1, 71.4, 71.5, S20 72.0, 73.1, 73.2, 73.4, 73.5, 73.6, 74.2, 74.5, 74.6, 74.7, 74.8, 75.0, 75.7, 76.1, 77.2, 77.4, 78.6, 79.3, 79.5, 79.7, 80.9, 92.8, 100.0, 100.8, 101.2, 101.4, 127.0, 127.3, 127.4, 127.45, 127.5, 127.6, 127.65, 127.7. 127.76, 127.8, 127.86, 127.9, 128.1, 128.15, 128.2, 128.24, 128.3, 128.4, 128.46, 128.5, 128.6, 128.8, 128.9, 132.3, 132.34, 137.6, 137.7, 137.8, 137.86, 137.94, 138.0,138.2, 138.45, 138.5, 139.0, 140.7, 141 -4.51, 17.96, 25.76, 57.9, 58.8, 63.1, 66.3, 67.7, 68.3, 68.5, 68.7, 69.5, 69.7, 70.0, 70.9, 71.1, 71.2, 72.9, 73.2, 73.5, 73.6, 73.9, 74.3, 74.5, 74.7, 75.1, 75.9, 76.9, 77.2, 77.6, 78.4, 78.5, 79.1, 82.8, 92.8, 98.0, 100.0, 100.8, 101.9, 126.6, 126.9, 126.96, 127.0, 127.1, 127.2, 127.3, 127.4, 127.5, 127.6, 127.64, 127.7, 127.85, 127.9, 128.0, 128.1, 128.2, 128.25, 128.3, 128.34, 128.36, 128.4, 128.5, 128.6, 128.7, 129.0, 129.4, 129.55, 129.6, 129.64, 129.76, 129.82, 129.9, 130.0, 130.1, 132.1, 132.3, 132.9, 133.0, 133.1, 133.2, 137.4, 137.5, 137.6, 137.7, 137.74, 137.8, 137.9, 138.0, 138.3, 138.4, 139.1, 140.6, 141.1, 165.1, 165.4, 165.5, 166. -4.5, 18.0, 25.7, 58.0, 58.4, 61.8, 66.1, 67.6, 67.7, 68.0, 68.7, 69.8, 70.3, 71.2, 71.6, 71.9, 72.0, 73.0, 73.3, 73.5, 73.6, 74.0, 74.4, 74.5, 74.7, 74.9, 75.0, 75.6, 76.0, 77.2, 78.5, 79.2, 79.8, 80.8, 92.8, 99.7, 100.7, 101.1, 101.4, 126.9, 127.0, 127.1, 127.2, 127.4, 127.5, 127.6, 127.7, 127.73, 127.8, 127.82, 127.86, 127.9, 128.0, 128.1, 128.2, 128.24, 128.3, 128.36, 128.4, 128.5, 128.7, 128.8, 128.84, 128.9, 129.5, 132.2, 132.3, 132.8, 137.5, 137.6, 137.7, 137.8, 137.9, 138.4, 138.43, 138.9, 140.6, 141. -4.5, 18.0, 25.8, 55.6, 57.9, 58.3, 67.8, 68.0, 68.1, 68.2, 69.9, 71.7, 72.2, 72.4, 72.45, 52.5, 72.6, 72.8, 72.85, 73.0, 73.1, 73.3, 73.34, 73.6, 73.7, 73.9, 74.2, 74.3, 74.4, 74.5, 74.7, 74.9, 75.0, 75.7, 76.0, 76.4, 77.2, 77.8, 78.5, 79.3, 79.8, 79.85, 82.2, 82.4, 92.7, 96.1, 96.8, 97.9, 99.3, 100.7, 101.4, 102.5, 102.7, 102.8, 122.6, 122.9, 123.0, 125.3, 126.6, 126.9-128.6, 128.8, 129.0, 131.6, 131.8, 131.9, 132.3, 133.1, 133.2, 133.4, 137.4, 138.0, 138.1, 138.2, 138.3, 138.4-138.6, 138.7, 138.8, 138.9, 138.95, 139.0, 139.1, 140.7, 141.14, 166.9, 167.4, 167.8, 168.0, 168.2, 168.4 -3.7, 19.1, 24.2, 24.3, 26.8, 57.8, 58.9,59.7, 59.8, 67.5, 67.7, 69.1-69.7, 70.4, 70.6, 71.2, 71.4, 72.3, 72.7, 73.1, 73.5, 73.6, 73.8, 73.9-74.7, 75.1-75.5, 75.6-76.3, 76.5, 76.6, 77.5, 77.8, 78.0, 78.1, 78.3, 78.5, 78.8, 78.9, 79.3, 80.8, 81.0, 81.1, 81.2, 81.3, 81.4, 83.7, 83.8, 94.4, 99.2, 100.1, 100.4, 101.6, 102.2, 102.4, 103.8, 104.1, 104.15, 125.2, 125.4-126.4, 127.5-130.4, 137.8, 137.9, 138.4, 139.5, 139.55, 139.6, 139.7 139.8, 139.9, 139.93, 140.0, 140.06, 140.1, 140.3, 140.4, 140.5, 141.08, 141.13, 141.5, 142.2, 142.6, 170.8, 171.3 THF (1.0 mL) was added, and the reaction was continued to be stirred for 120 min at -78° C.
Upon removing the cold finger, solid NH 4 Cl (100 mg) was added and the suspension was vigorously stirred until the blue color disappeared. The reaction vessel was subsequently removed from its cooling bath, warmed to 25° C, and the resulting white solid was dried for 3h.
This residue was suspended in sat. aq. NaHCO 3 (4.0 ml), the mixture was cooled in an ice bath and treated with Ac 2 O (0.2 ml). The reaction mixture was warmed to room temperature and stirred for 2h. The whole solution was then purified with Bio-Rad P-2 gel filtration column to afford the desired deprotected saccharide 37 as a mixture of "/#-anomers (8.9 mg, 94% Glycosylamine 38 was aspartylated with hexapeptide 25 following the protocol described for the preparation of 26a to provide 39a in 25% yield (from the reducing saccharide 37) after purification by HPLC and lyophilization. ESI-MS: Calcd. for C 76 -5.7, -4.5, 18.0, 25.8, 55.6, 58.0, 67.6, 67.7, 68.1-68.3, 70.1, 72.2, 72.3, 72.7-73.0, 73.2-73.4, 73.7, 73.8, 74.0, 74.2, 74.3-74.5, 74.7, 74.9, 75.0, 75.2, 76.0, 76.2, 77.2, 77.7, 78.0, 78.8, 79.8, 79.7, 80.0, 82.2, 82.3, 82.4, 82.5, 92.7, 99.2, 100.8-101.3, 102.4-103.1, 122.5-123.6, 126.4-129.2, 131.4-131.9, 132.4, 132.9-133.7, 137.6, 137.8-139.2, 140.8, 140.85, 166.0-168.4 -5.6, -4.4, 18.0, 25.8, 26.8, 27.2, 27.3, 67.9-68.3, 72.6, 72.7-73.0, 73.4, 73.5, 73.6, 74.0, 74.5-74.8, 75.0-75.3, 77.7, 77.8, 79.8, 79.9, 82.3, 82.34, 92.8, 100.6-100.8, 101.2-101.6, 102.7-103.0, 126.1, 126.7-129.0, 129.6, 130.5,130.9, 132.3, 132.4, 137.9-139.3, 139.8, 140.5, 141.3, 141.4, 170.0-171. Glycosylamine 43 was aspartylated with hexapeptide 25, following the protocol described for the preparation of 26a, to provide 44a. This compound was used directly in the deprotection (see 44)
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after HPLC purification and partial concentration from DMF (DMF was added to avoid foaming of the solution The 11+21 glycopeptide (1.05 mg, 0.246 µmol) was solublized in degassed water, and added to the activated KLH (1.4 mg, 0.000175 µmol) stored in PBS EDTA 5 mM. Sodium carbonate (200 mM) was added to adjust the pH to 6.8. The reaction was allowed to proceed over 18 hours at room temperature. Purification and concentration of the conjugate was performed as described above for the activated KLH.
Immunization and hybridoma generation. A group of 5 BALB/c mice were immunized subcutaneously every two weeks for four weeks with the 11+21 glycopeptide conjugated to KLH. The animal which serum had the highest titer in antibodies recognizing the 11+21 glycopeptide was selected and subjected to a boost immunization. After two weeks, the animal was sacrificed and hybridomas were prepared according to standard protocols.
Enzyme-linked immunosorbent assays.
For screening of the hybridomas, a standard ELISA was conducted as follows. The 96-well plates (Nunc, Naperville, IL) were coated with 50 ng of 11+21 glycopeptide per well in PBS overnight at 4°C. The wells were washed 3 times with PBS/Tw (PBS containing 0.01% Tween 20) and once with PBS. The wells were then blocked with 300 µL 2% BSA in PBS for one hour at 37°C, and 50 µL hybridoma supernatant (1:50 dilution in 2% BSA PBS) was added to the wells. After one hour incubation at room temperature, the plates were again washed 3 times with PBS/Tw and once with PBS before adding 50 µL of a 1:1000 dilution of goat-antimouse immunoglobulin IgG and IgM antibody conjugated to alkaline phosphatase (Jackson ImmunoResearch,West Grove, PA). After washing, 50 µL of Turbo TMB (Pierce, Rockford, IL) was added per well, and the plates were read at 450 S36 nm in an ELISA plate reader after stopping the reaction by adding 50 µL 1N H 2 SO 4 . A negative control consisted of wells treated according to the same protocol, but incubated with an unrelated hybridoma supernatant. Selected positive hybridoma supernatants were tested for recognition of the 9+21 glycopeptide using the same protocol.
For characterizing the reactivity of selected hybridoma supernatants towards tumor PSA, a sandwich ELISA was conducted as follows. Desialylation of LnCap PSA from cell culture supernatant was performed using sialidase A according to the suggested protocol from the manufacturer (Prozyme, San Leandro, CA). 5 ng LnCap PSA, pretreated or not with sialidase was added to 96-well plates precoated with rabbit anti-PSA (Alpco Diagnostics, Salem, NH).
After one hour incubation at room temperature, the plates were washed 3 times with PBS/Tw and once with PBS before adding 50 µL undiluted hybridoma supernatant to the wells. The protocol was then identical to the standard ELISA described above. A negative control consisted of wells treated according to the same protocol, but incubated with an unrelated hybridoma supernatant.
Positive control wells were incubated with H117 anti-PSA antibody. 
